Form 4: Hims & Hers CMO Receives Equity Compensation

Chief Medical Officer Patrick Harrison Carroll received 435 restricted stock units in lieu of cash director fees.

Summary

• Patrick Harrison Carroll, Chief Medical Officer of Hims & Hers Health, Inc., was granted 435 Restricted Stock Units (RSUs).
• The grant was issued in lieu of a $10,000 cash director retainer fee for the first quarter of 2026.
• The RSUs were valued at a grant price of $22.98 per share.
• The units are scheduled to vest in full on the company's next quarterly vesting date, June 15, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding executive compensation with no material impact on the company's financial outlook.

Positives

• Alignment of executive interests with shareholders through equity-based compensation.
• Preservation of company cash reserves by opting for stock-based compensation for director fees.

Negatives

• None identified.

Risks

• Market volatility affecting the value of equity compensation.
• Potential dilution of existing shareholders, though the amount is negligible.

Future Outlook

The RSUs are set to vest on June 15, 2026, at which point the reporting person will receive shares of Class A Common Stock.

Industry Context

StockSavvy.ai notes that it is common practice for executives and directors to receive equity in lieu of cash fees to demonstrate long-term commitment to the company's growth trajectory.

Comparison to Industry Standards

• The use of equity-based compensation for director fees is a standard corporate governance practice among mid-cap growth companies to conserve cash and align incentives.

Corporate Governance

Stakeholder Impact

• Minimal impact on shareholders due to the small size of the equity grant.

Next Steps

• Vesting of the 435 RSUs on June 15, 2026.

Key Dates

Keywords

Hims & Hers, HIMS, Form 4, Insider Trading, Equity Compensation, Restricted Stock Units